| Mrs Miranda Renee Wing, NP | |
|
1 Catamore Blvd, E Providence, RI 02914 | |
| (401) 438-0008 | |
| (401) 438-2272 |
| Full Name | Mrs Miranda Renee Wing |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 1 Catamore Blvd, E Providence, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376898569 | NPI | - | NPPES |
| 2316320 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | APRN01755 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Miranda Renee Wing, NP 1 Catamore Blvd, E Providence, RI 02914 Ph: (401) 438-0008 | Mrs Miranda Renee Wing, NP 1 Catamore Blvd, E Providence, RI 02914 Ph: (401) 438-0008 |
News Archive
A specific genetic region that has been increasingly identified as the strongest genetic link to psoriasis has an even more significant role in the chronic skin disease than has been suspected, University of Utah medical researchers show in a new study.
Kemin Foods, L.C. ("Kemin") and OmniActive Health Technologies, Inc. and OmniActive Health Technologies, Ltd. ("OmniActive") have reached an amicable settlement of their dispute.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Canadian researchers have launched the world's first clinical trial of a novel investigational therapy that uses a combination of two viruses to attack and kill cancer cells, and stimulate an anti-cancer immune response. Previous research by this team and others worldwide suggests that this approach could be very powerful, and could have fewer side effects than conventional chemotherapy and radiation, although it will take years to rigorously test through this trial and others.
Protectus Medical Devices, Inc., developer and marketer of innovative safety medical devices, announced today it has received Notice of Allowance from the US Patent and Trademark Office on its patent application describing a spring-activated, automatic, self-sheathing Safety Syringe, a major step toward it becoming the gold standard in safety syringe devices.
› Verified 1 days ago
Jessica Leblanc, RNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 400 Massasoit Ave, Suite 300, E Providence, RI 02914 Phone: 401-434-2704 | |
Mr. Samuel David Kaufman, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 34 Rice Ave, E Providence, RI 02914 Phone: 617-799-5416 | |
Bethany A Erickson-caron, RNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 450 Veterans Memorial Pkwy Bldg 6, E Providence, RI 02914 Phone: 401-435-5533 Fax: 401-431-2555 |